Mesenchymal stem cells: a new therapeutic tool for AKI. (Q42650891)

4 November 2017

1 reference

title

Mesenchymal stem cells: a new therapeutic tool for AKI. (English)

1 reference

4 November 2017

mesenchymal stem cell

1 reference

Florian E Tögel

1

1 reference

PubMed ID

20186233

4 November 2017

Christof Westenfelder

series ordinal

2

1 reference

PubMed ID

20186233

4 November 2017

language of work or name

English

0 references

publication date

1 March 2010

1 reference

Nature Reviews Nephrology

4 November 2017

1 reference

4 November 2017

6

1 reference

4 November 2017

179-183

1 reference

4 November 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneph.2009.229

4 November 2017

0 references

cites work

Diagnosis, epidemiology and outcomes of acute kidney injury.

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.229

Renal recovery following acute kidney injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.229

On the design and analysis of multicenter trials in acute renal failure.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.229

Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.229

Creatinine kinetics and the definition of acute kidney injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.229

Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.229

A rapid urine test for early detection of kidney injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.229

Paracrine mechanisms in adult stem cell signaling and therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.229

Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.229

VEGF is a mediator of the renoprotective effects of multipotent marrow stromal cells in acute kidney injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.229

Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.229

Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.229

Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.229

Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.229

Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.229

Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.229

Mesenchymal stem cell-derived microvesicles protect against acute tubular injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.229

Insulin-Like Growth Factor-1 Sustains Stem Cell Mediated Renal Repair

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.229

Cell biology and molecular mechanisms of injury in ischemic acute renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.229

From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.229

Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.229

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.229

Acute renal failure in the new millennium: time to consider combination therapy.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20186233

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRNEPH.2009.229

1 reference

4 November 2017

1 reference

PubMed ID

20186233